GlassScriptPhysician profile
Jaclyn Dovico
NPI 1205280864
$1,091.93
in general payments reported to CMS, 2019-2025
18 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.35 · 2020: $97.26 · 2021: $224 · 2022: $143 · 2023: $165 · 2024: $305 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $292.76 | 2020-2024 | Dyanavel Xr |
| Sanofi-Aventis U.S. LLC | $135.97 | 2023-2025 | |
| Glaxosmithkline, LLC. | $128.72 | 2022-2025 | Bexsero, Pediarix |
| Merck Sharp & Dohme LLC | $101.72 | 2019-2024 | Gardasil 9, Vaxneuvance, M-M-R II |
| Corium, LLC | $56.64 | 2023-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $55.48 | 2024 | |
| Kaleo, INC. | $50.69 | 2019-2021 | |
| Davol INC. | $43.12 | 2024 | Phasix Mesh |
| Pfizer INC. | $40.73 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $39.92 | 2021-2024 | Qelbree |
| Sobi, INC | $30.90 | 2021 | |
| Adlon Therapeutics L.P. | $19.45 | 2020 | |
| Organon LLC | $19.01 | 2025 | Nexplanon |
| Aytu Biopharma, INC. | $17.96 | 2022 | |
| Acadia Pharmaceuticals INC | $17.88 | 2024 | Daybue |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.08 | 2025 | Jornay Pm |
| Biogen, INC. | $12.68 | 2021 | |
| Neos Therapeutics, LP | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Dovico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.